The Global Pharmaceutical Grade Albendazole Market was valued at USD 865 Million in 2025 and is projected to reach USD 1206 Million by 2034, growing at a Compound Annual Growth Rate (CAGR) of 5.0% during the forecast period. This growth is primarily driven by the high global burden of parasitic infections, expanding government deworming programs, rising awareness about zoonotic diseases, and increasing investments in healthcare infrastructure across emerging economies.
As global health initiatives intensify the fight against neglected tropical diseases (NTDs), the focus sharpens on the key active pharmaceutical ingredient (API) manufacturers ensuring the supply of high-quality anthelmintic treatments. In this blog, we profile the Top 10 Companies in the Pharmaceutical Grade Albendazole Industry—a mix of established pharma giants and specialized API producers shaping the accessibility and efficacy of parasitic disease control worldwide.
Download FREE Sample Report:
Pharmaceutical Grade Albendazole Market – View in Detailed Research Report
🔟 1. ALIVIRA ANIMAL HEALTH LTD (A GROUP CO OF SEQUENT SCIENTIFIC LTD)
Headquarters: Mumbai, Maharashtra, India
Key Offering: Albendazole API (Purity ≥99%), Veterinary and Human Grade Formulations
ALIVIRA Animal Health, part of the Sequent Scientific group, is a leading manufacturer of Albendazole, serving both the pharmaceutical and veterinary markets. The company operates WHO-GMP certified facilities and has a strong presence in regulated and emerging markets, supplying critical APIs for deworming medications.
Manufacturing & Quality Initiatives:
-
WHO-GMP and ISO certified manufacturing plants
-
Strong vertical integration from API to finished formulations
-
Significant exports to Africa, Southeast Asia, and Latin America for public health programs
9️⃣ 2. KOYE PHARMACEUTICALS PRIVATE LTD
Headquarters: Hyderabad, Telangana, India
Key Offering: Pharmaceutical Grade Albendazole, Albendazole Tablets & Suspensions
Koye Pharmaceuticals specializes in the development and manufacturing of Albendazole and other anthelmintic APIs. The company focuses on stringent quality control and cost-effective production, making it a key supplier for generic pharmaceutical companies globally.
Manufacturing & Quality Initiatives:
-
Focus on high-purity Albendazole production
-
Compliant with various international pharmacopoeia standards (USP, BP, IP)
8️⃣ 3. CADILA HEALTHCARE LTD (ZYDUS CADILA)
Headquarters: Ahmedabad, Gujarat, India
Key Offering: Albendazole API, Branded & Generic Formulations (Zentel)
Zydus Cadila is a globally recognized pharmaceutical company with a robust portfolio that includes Albendazole. Its brand ‘Zentel’ is widely used in mass drug administration programs. The company’s large-scale manufacturing capabilities ensure a steady supply for both domestic and international health campaigns.
Manufacturing & Quality Initiatives:
-
USFDA-approved manufacturing facilities
-
Active participation in global NTD eradication initiatives
-
Continuous investment in R&D for improved drug delivery systems
7️⃣ 4. NOVUGEN PHARMA MALAYSIA SDN BHD
Headquarters: Selangor, Malaysia
Key Offering: High-Purity Albendazole API
Novugen Pharma is a significant player in the Southeast Asian pharmaceutical market, specializing in APIs like Albendazole. The company leverages its strategic location and modern manufacturing infrastructure to serve regional and international customers with high-quality products.
Manufacturing & Quality Initiatives:
-
Modern API synthesis and purification technologies
-
Adherence to ASEAN and international regulatory standards
Download FREE Sample Report:
Pharmaceutical Grade Albendazole Market – View in Detailed Research Report
6️⃣ 5. MSN LIFE SCIENCES PRIVATE LTD
Headquarters: Hyderabad, Telangana, India
Key Offering: Albendazole API, Intermediates
MSN Life Sciences is a leading manufacturer of APIs, including Albendazole, with a strong focus on research and development. The company supplies to numerous formulation companies worldwide and is known for its reliable supply chain and consistent quality.
Manufacturing & Quality Initiatives:
-
Multiple regulatory approvals for its manufacturing sites
-
Integrated manufacturing with control over key starting materials
5️⃣ 6. CIPLA LTD
Headquarters: Mumbai, Maharashtra, India
Key Offering: Albendazole Tablets, Suspensions, APIs
Cipla is a global pharmaceutical giant with a profound commitment to making affordable medicines accessible. The company produces and markets Albendazole under various brand names and is a major supplier to public health organizations for deworming programs in low- and middle-income countries.
Manufacturing & Quality Initiatives:
-
World-class manufacturing facilities compliant with global standards
-
Extensive distribution network across over 80 countries
-
Strategic partnerships with global health bodies like the WHO
4️⃣ 7. SOLARA ACTIVE PHARMA SCIENCES LTD
Headquarters: Chennai, Tamil Nadu, India
Key Offering: Albendazole API (Various Grades)
Solara Active Pharma Sciences is a focused API company with a significant portfolio that includes Albendazole. It is dedicated to manufacturing complex APIs and has built a reputation for quality and reliability in the regulated markets of the US and Europe.
Manufacturing & Quality Initiatives:
-
Strong regulatory track record with USFDA and EMA
-
Emphasis on developing environmentally sustainable manufacturing processes
3️⃣ 8. UQUIFA MEXICO SA DE CV
Headquarters: Mexico City, Mexico
Key Offering: Albendazole API for Latin American Markets
UQUIFA is a prominent API manufacturer with a strong foothold in the Latin American region. The company produces Albendazole and serves local pharmaceutical companies, contributing to regional health programs aimed at controlling parasitic diseases.
Manufacturing & Quality Initiatives:
-
Compliance with COFEPRIS (Mexican health authority) and other regional regulations
-
Strategic location for serving the Americas
2️⃣ 9. UNIMARK REMEDIES LTD
Headquarters: Mumbai, Maharashtra, India
Key Offering: Albendazole API and Intermediates
Unimark Remedies is a specialized manufacturer of APIs, including Albendazole, with a focus on the veterinary and human health sectors. The company exports its products to several countries and is known for its technical expertise in chemical synthesis.
Manufacturing & Quality Initiatives:
-
Manufacturing plants designed to meet international cGMP standards
-
Robust R&D capabilities for process optimization
1️⃣ 10. GlaxoSmithKline plc (GSK)
Headquarters: London, United Kingdom
Key Offering: Albendazole (as part of its global health portfolio)
While not a primary API manufacturer, GSK is a crucial player in the Albendazole ecosystem through its extensive global health initiatives. The company has historically been a major donor of Albendazole for lymphatic filariasis and soil-transmitted helminthiasis control programs, working closely with the WHO and other partners.
Global Health Initiatives:
-
Long-standing donations of billions of Albendazole tablets for NTD programs
-
Commitment to the London Declaration on NTDs
-
Investment in R&D for new anthelmintic agents
Get Full Report Here:
Pharmaceutical Grade Albendazole Market – View in Detailed Research Report
🌍 Outlook: The Future of Pharmaceutical Grade Albendazole is Preventive and Accessible
The Pharmaceutical Grade Albendazole market is evolving from a treatment-focused commodity to a cornerstone of global preventive healthcare. While generic production continues to dominate, the industry is witnessing increased focus on combination therapies, pediatric formulations, and supply chain resilience to meet the ambitious targets of NTD eradication programs.
📈 Key Trends Shaping the Market:
-
Expansion of government-led Mass Drug Administration (MDA) programs in Africa and Asia
-
Growing integration of deworming with other primary healthcare services
-
Rising demand for high-purity APIs from stringent regulatory markets
-
Strategic partnerships between API manufacturers, NGOs, and international health bodies to ensure supply security
Get Full Report Here:
Pharmaceutical Grade Albendazole Market – View in Detailed Research Report
The companies listed above are not only producing a critical pharmaceutical ingredient—they are enabling the global mission to alleviate the burden of parasitic diseases on millions of lives.
- Top 10 Companies in the Lanoceric Acid Industry (2024): Market Leaders Powering Cosmetic and Pharmaceutical Innovation - February 18, 2026
- Top 10 Companies in the Palladium Nitrate Recovery Industry (2026): Market Leaders Driving Sustainable Resource Management - February 18, 2026
- Top 10 Companies in the Organic Silicon Gel Industry (2026): Market Leaders Powering Global Innovation - February 18, 2026
